110 related articles for article (PubMed ID: 1682278)
1. Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer.
Ludwig CU; Raefle G; Dalquen P; Stulz P; Stahel R; Obrecht JP
Int J Cancer; 1991 Nov; 49(5):661-5. PubMed ID: 1682278
[TBL] [Abstract][Full Text] [Related]
2. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Genes Chromosomes Cancer; 1994 Jul; 10(3):183-9. PubMed ID: 7522041
[TBL] [Abstract][Full Text] [Related]
3. The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus.
Glaser T; Lewis WH; Bruns GA; Watkins PC; Rogler CE; Shows TB; Powers VE; Willard HF; Goguen JM; Simola KO
Nature; 1986 Jun 26-Jul 2; 321(6073):882-7. PubMed ID: 3014343
[TBL] [Abstract][Full Text] [Related]
4. Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
Shipman R; Schraml P; Colombi M; Ludwig CU
Int J Oncol; 1998 Jan; 12(1):107-11. PubMed ID: 9454893
[TBL] [Abstract][Full Text] [Related]
5. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
Tran YK; Newsham IF
Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
[TBL] [Abstract][Full Text] [Related]
6. Deletion mapping of chromosome 11 in carcinoma of the bladder.
Shaw ME; Knowles MA
Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.
Viel A; Giannini F; Tumiotto L; Sopracordevole F; Visentin MC; Boiocchi M
Br J Cancer; 1992 Dec; 66(6):1030-6. PubMed ID: 1360809
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
[TBL] [Abstract][Full Text] [Related]
9. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.
Weston A; Willey JC; Modali R; Sugimura H; McDowell EM; Resau J; Light B; Haugen A; Mann DL; Trump BF
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5099-103. PubMed ID: 2567993
[TBL] [Abstract][Full Text] [Related]
10. Frequency and extent of allelic loss in the short arm of chromosome 3 in nonsmall-cell lung cancer.
Rabbitts P; Douglas J; Daly M; Sundaresan V; Fox B; Haselton P; Wells F; Albertson D; Waters J; Bergh J
Genes Chromosomes Cancer; 1989 Sep; 1(1):95-105. PubMed ID: 2577272
[TBL] [Abstract][Full Text] [Related]
11. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
[TBL] [Abstract][Full Text] [Related]
12. [Allelic losses on chromosomes 1p, 3p, 11p, 11q in non small cell lung cancers].
Cheng JQ; Crépin M; Hamelin R
C R Acad Sci III; 1990; 311(5):175-9. PubMed ID: 2169974
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
14. Parental origin of 11p15 deletions in human lung cancer.
Kondo M; Suzuki H; Ueda R; Takagi K; Takahashi T; Takahashi T
Oncogene; 1994 Oct; 9(10):3063-5. PubMed ID: 7916149
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of chromosome 9 in human primary non-small cell lung cancer.
Merlo A; Gabrielson E; Askin F; Sidransky D
Cancer Res; 1994 Feb; 54(3):640-2. PubMed ID: 8306323
[TBL] [Abstract][Full Text] [Related]
16. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer.
Neville EM; Stewart M; Myskow M; Donnelly RJ; Field JK
Oncogene; 1995 Aug; 11(3):581-5. PubMed ID: 7630642
[TBL] [Abstract][Full Text] [Related]
20. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer.
Bepler G; Garcia-Blanco MA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5513-7. PubMed ID: 8202519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
